ALNY vs ASGN · P/E 76, rev $1.29B vs P/E 14, rev $4.10B
Alnylam Pharmaceuticals Inc (ALNY) versus ASGN Inc (ASGN) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
ASGN Inc (ASGN) is a information technology services company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported ASGN revenue for 2024-12-31 was $4.10B. Net income was $175.2M. Revenue was down 7.9% from 2023-12-31 to 2024-12-31. ASGN currently screens at market cap $2.20B and trailing P/E 14.3.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. ASGN currently screens at market cap $2.20B and trailing P/E 14.3.
Not investment advice. Open the ALNY and ASGN stock pages for the full models.
Not investment advice.